Low-Reynolds-number fluids make viscous effects especially important for microrobotic movement. At these scales, devices cannot rely on the same inertial behavior as larger robots; instead, propulsion and steering must be matched to fluid conditions. This consideration helps explain why magnetic, acoustic, optical, and chemical forces are central to their operation.
These force types provide alternative ways to propel and control microrobots. Magnetic, acoustic, optical, and chemical actuation are externally applied, allowing wireless operation in settings where onboard conventional propulsion may be impractical. The appropriate choice depends on the biological environment, intended task, and required control precision.
Biocompatibility determines whether a device can interact with biological environments without undermining its intended use. Localization identifies where the microrobot is, while control governs its movement and task performance. Treating these as linked design requirements is important for targeted delivery, tissue manipulation, and other bioengineering applications where precision matters.
Microrobotics can contribute to targeted drug delivery by bringing wireless, externally controlled devices into biological environments where localized interaction is valuable. Their small dimensions allow interaction with cells, tissues, and fluids, while engineered propulsion and control support movement toward an intended site. The potential outcome is more precise therapy.
Beyond delivery, microrobots can serve as tools for biosensing and tissue manipulation, and they may support minimally invasive procedures. These uses rely on the ability to move through biological environments and interact with relevant structures at small scales. Consequently, the same platform concept can support therapeutic interventions and experimental study of biological systems.
Microrobotics gives bioengineers a way to study biological systems through controlled interaction with cells, tissues, and fluids. Research can therefore examine not only therapeutic uses but also how small engineered devices behave in complex biological environments. Progress is tied to solving biocompatibility, propulsion, localization, and control challenges that determine whether these tools perform reliably.